Actinium Pharmaceuticals, Inc. (ATNM)

Operating Expenses

$7.44M

Quarterly · Period ending: · USD

ATNM logo

ATNM Operating Expenses

Latest reported$7.44M
ATNM Quarterly Operating Expenses ($10.03K → $7.44M)
High-resolution chart · PNG

ATNM operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Actinium Pharmaceuticals, Inc. Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
7,435,000
5,683,000
7,029,000
5,782,000
7,503,000
16,638,000
7,301,000
12,399,000
12,229,000
9,381,000
10,225,000
14,151,000
15,433,000
11,584,000
11,130,000
9,623,000
7,715,000
5,967,000
7,934,000
6,702,000
5,341,000
5,994,000
6,435,000
5,613,000
4,662,000
5,683,000
4,529,114
6,652,000
5,086,000
5,699,000
6,364,000
6,197,000
4,913,000
6,354,000
5,207,000
6,695,000
7,203,000
7,806,000
6,827,000
7,101,000
6,918,000
6,002,000
4,920,000
4,640,000
7,405,000
7,866,000
6,873,000
7,045,000
4,425,000
4,138,000
1,484,000
1,609,000
1,476,000
2,019,000
7,932,000
2,399,000
839,339
1,005,320
1,144
2,430
3,361
2,680
6,769
7,942
4,181
6,513
6,314
2,232
2,111
3,878
6,316
2,094
8,304
9,705
4,500
4,653
2,840
-435
7,504
10,030
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.